Posts


EU HIV diagnoses plateau as campaigners demand new action plan

Despite much improvement in recent years, HIV transmission in the EU is no longer decreasing. The figure has stabilised, and the European Centre for ... View article...

Is Aspen right to abandon lenacapavir for an unproven HIV prevention pill?

... antiretroviral drug tenofovir. Apart from the tablets, ideally taken daily, HIV transmission could also be prevented by the correct use of condoms ... View article...

HIV injections every eight weeks more effective than daily pills for adolescents

... antiretroviral treatment compared to adults. “HIV-positive adolescents as a group have historically done worse on antiretrovirals compared to adults. View article...

The ActHIVate Fund: Strengthening Community-Led HIV Responses

The ActHIVate Fund, initiated by Aidsfonds, is a new funding mechanism aimed at enhancing community-led HIV responses for trans and men who have ... View article...

NICE rejects long-acting HIV prevention treatment for NHS use

Lenacapavir, a twice-yearly injection to reduce the risk of HIV infection, should not be routinely available as preventative treatment. View article...

HIV clinics in South Africa shrink as US PEPFAR funding is cut

Activist Yvette Raphael, living with HIV for more than 20 years, says US cuts to South Africa's HIV funding were felt “overnight” as mobile and ... View article...

People living with HIV held in isolation after LGBTI+ arrests, group says

" HIV status can never be grounds for isolation," Pozitif Alan said, noting that the virus is not transmitted through everyday contact, including ... View article...

Structural basis of lenacapavir-induced HIV-1 capsid defects during virion maturation

Long-acting lenacapavir (LEN) has emerged as a highly effective, potentially game-changing therapy for HIV treatment and prevention. View article...